Off-label Use Analysis of Tacrolimus Combined with Wuzhi Capsules in One Membranous Nephropathy Patient
- VernacularTitle:膜性肾病患者他克莫司合并五酯胶囊的超说明书用药分析
- Author:
Dongxue WANG
;
Linlin WU
;
Dasheng ZHU
;
Xiujuan FU
- Publication Type:Journal Article
- Keywords:
Membranous nephropathy;
Tacrolimus;
Wuzhi capsules;
Off-label drug use
- From:
China Pharmacist
2016;19(10):1908-1910
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the rationality of off-label use of tacrolimus combined with Wuzhi capsules in a membranous nephropathy patient. Methods:Based on the related literatures, the application rationality of tacrolimus combined with Wuzhi capsules in a membranous nephropathy patient was analyzed. Results:The combination of tacrolimus and Wuzhi capsules against membranous nephropathy was an off -label drug use, however, it showed certain clinical rationality and economic efficiency. Conclusion:Off-label drug use commonly exists in clinics. Clinical pharmacists should provide evidence support for off-label drug use through searching and analyzing clinical evidences and closely monitoring therapeutic outcome.
